Lapatinib and Trastuzumab
About
Membership operator: AND
Therapies: 2
Therapies
Lapatinib (tx:ncit:C26653)
Trastuzumab (tx:ncit:C1647)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | ER positive, HER2-positive, PR negative | Invasive Breast Carcinoma | Lapatinib, Trastuzumab | |
| EMA (1) | ER positive, ERBB2 amplification, PR negative | Invasive Breast Carcinoma | Lapatinib, Trastuzumab |